Temple’s Department of Thoracic Medicine and Surgery has one of the most active and wide-ranging pulmonary research programs in the country. The department’s physician scientists have led research into the causes of and effective therapies for COPD, emphysema, alpha 1-antitrypsin deficiency, asthma, lung cancer, pulmonary hypertension, sarcoidosis, pulmonary fibrosis and sleep apnea. In addition, Temple consistently ranks among the highest enrolling sites for pulmonary clinical trials in the nation.
Research programs and centers at Temple include:
The mission of Temple’s Center for Inflammation, Translational and Clinical Lung Research (CILR) is to promote basic, pre-clinical, translational and clinical research in the field of inflammation and lung disease. It is also CILR’s objective to train scientists interested in the study of these processes, and to broaden the awareness and understanding of lung disease in the community.